Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.275
-0.005 (-0.39%)
Mar 31, 2025, 1:40 PM EDT - Market open
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $86.03 million as of March 31, 2025. Its market cap has increased by 10.64% in one year.
Market Cap
86.03M
Enterprise Value
-125.63M
1-Year Change
10.64%
Ranking
Category
Stock Price
1.28
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $86.03M, a decrease of -78.66%. That is a compound annual growth rate of -34.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 86.37M | -28.62% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |